Biotech

IGM Biosciences Halts Lead Autoimmune Programs, Cuts Workforce by 73%

IGM Biosciences is discontinuing its lead autoimmune programs, imvotamab and IGM-2644, following disappointing clinical results, and implementing a 73% workforce reduction while reevaluating its strategic direction.

Verdiva Bio Launches with $411M Funding to Revolutionize Obesity and Cardiometabolic Care

Biotech Startup Unveils Next-Generation Therapies, Including a Promising Once-Weekly Oral GLP-1 Peptide, Backed by Leading Global Investors.

The Four Powerhouses of DNA Sequencing

Dive into the leading DNA sequencing technologies driving genomic discovery from Oxford Nanopore, Illumina, PacBio, and 10x Genomics.

AbbVie Expands Immunology Pipeline with Acquisition of Nimble Therapeutics and Aliada Therapeutics

AbbVie has bolstered its immunology and immuno-oncology portfolios by acquiring Nimble Therapeutics and Aliada Therapeutics, key players in preciscion medicine and cancer immune modulation.

Biotechnology in Agriculture - Feeding the World’s Growing Population

Explore the key biotech innovations that offer to address the challenges of sustainably feeding a growing global population and the hurdles such as scalability, regulation, and consumer acceptance that must be overcome.

Asimov and Revopsis Therapeutics Enter Strategic Licensing Agreement to Advance Gene Therapy Solutions

This partnership is set to combine Asimov’s cutting-edge gene editing platform with Revopsis’s expertise in rare genetic diseases, potentially accelerating the development of next-generation gene therapies.